Literature DB >> 3132788

Thyroid function in severely traumatized patients with or without head injury.

R L Chioléro1, T Lemarchand-Béraud, Y Schutz, N de Tribolet, M Bayer-Berger, J Freeman.   

Abstract

The pattern of thyroid function changes following severe trauma was assessed prospectively in 35 patients during the first 5 days after injury. Patients were divided into 2 groups to evaluate the effect of head injury: group I, patients with severe head injury; group II, patients with multiple injuries without head injury. The results demonstrate a low T3 and low T4 syndrome throughout the study, with decreases in both total and free levels of T3 and T4, normal or increased rT3 levels, and normal TSH levels. The presence of severe head injury was associated with lower levels of TSH and free T3. Mortality was 37%. Survival was associated with higher TSH and T3 levels, but not with higher T4 levels. TSH levels exceeding 1 mU/l on the first day were only observed in survivors. These findings show that a typical low T3 and low T4 syndrome is present after severe trauma in patients with multiple injury as well as with head injury. Primary hypothyroidism can be excluded, pituitary or hypothalamic hypothyroidism is likely in these patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3132788     DOI: 10.1530/acta.0.1170080

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  12 in total

Review 1.  Endocrine changes after pediatric traumatic brain injury.

Authors:  Susan R Rose; Bethany A Auble
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

2.  The secretion of human growth hormone stimulated by human growth hormone releasing factor following severe cranio-cerebral trauma.

Authors:  M Gottardis; C Nigitsch; E Schmutzhard; M Neumann; C Putensen; J M Hackl; W Koller
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

3.  Acute gonadotroph and somatotroph hormonal suppression after traumatic brain injury.

Authors:  Justin Wagner; Joshua R Dusick; David L McArthur; Pejman Cohan; Christina Wang; Ronald Swerdloff; W John Boscardin; Daniel F Kelly
Journal:  J Neurotrauma       Date:  2010-06       Impact factor: 5.269

Review 4.  Hypothalamic-pituitary dysfunction in critically ill patients with traumatic and nontraumatic brain injury.

Authors:  Ioanna Dimopoulou; Stylianos Tsagarakis
Journal:  Intensive Care Med       Date:  2005-06-15       Impact factor: 17.440

5.  Prospective investigation of anterior pituitary function in the acute phase and 12 months after pediatric traumatic brain injury.

Authors:  Halil Ulutabanca; Nihal Hatipoglu; Fatih Tanriverdi; Abdülkerim Gökoglu; Mehmet Keskin; Ahmet Selcuklu; Selim Kurtoglu; Fahrettin Kelestimur
Journal:  Childs Nerv Syst       Date:  2013-12-10       Impact factor: 1.475

6.  Relations between the selenium status and the low T3 syndrome after major trauma.

Authors:  M M Berger; T Lemarchand-Béraud; C Cavadini; R Chioléro
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

7.  Thyroid and thymic endocrine function and survival in severely traumatized patients with or without head injury.

Authors:  E Mocchegiani; R Imberti; D Testasecca; M Zandri; L Santarelli; N Fabris
Journal:  Intensive Care Med       Date:  1995-04       Impact factor: 17.440

Review 8.  Evidence Limitations in Determining Sexually Dimorphic Outcomes in Pediatric Post-Traumatic Hypopituitarism and the Path Forward.

Authors:  Alina Nico West; Alicia M Diaz-Thomas; Nadeem I Shafi
Journal:  Front Neurol       Date:  2020-11-26       Impact factor: 4.003

9.  Acute neuro-endocrine profile and prediction of outcome after severe brain injury.

Authors:  Zandra Olivecrona; Per Dahlqvist; Lars-Owe D Koskinen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2013-04-20       Impact factor: 2.953

Review 10.  Update of Endocrine Dysfunction following Pediatric Traumatic Brain Injury.

Authors:  Kent Reifschneider; Bethany A Auble; Susan R Rose
Journal:  J Clin Med       Date:  2015-07-31       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.